AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.
Cambridge, England-based AstraZeneca said that under the terms.
AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder
The Cambridge,.
/PRNewswire/ EDETEK Inc., a leading global provider of specialized software and services for the biopharma, devices and diagnostics industries, announced.
CORAL GABLES, Fla., May 30, 2023 Catalyst Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for. | May 30, 2023
Catalyst Pharmaceuticals (CPRX) Appoints Tamar Thompson to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.